Public-health impact of accelerated measles control in the WHO African Region 2000-03.
about
The use of supplementary immunisation activities to improve uptake of current and future vaccines in low-income and middle-income countries: a systematic review protocolYellow fever control in Cameroon: Where are we now and where are we going?Sun protection to improve vaccine effectiveness in children in a high ambient ultraviolet radiation and rural environment: an intervention studyEnhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013Unacceptably high mortality related to measles epidemics in Niger, Nigeria, and ChadMeasles still has a devastating impact in unvaccinated populations.System-level determinants of immunization coverage disparities among health districts in Burkina Faso: a multiple case studyComparison of LiST measles mortality model and WHO/IVB measles modelValidating child vaccination status in a demographic surveillance system using data from a clinical cohort study: evidence from rural South Africa.The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy.Biological feasibility of measles eradicationControlling measles using supplemental immunization activities: a mathematical model to inform optimal policy.Measles in a tertiary institution in bida, niger state, Nigeria: prevalence, immunization status and mortality pattern.Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination.Measles virus strain diversity, Nigeria and Democratic Republic of the CongoImmunological impact of an additional early measles vaccine in Gambian children: responses to a boost at 3 years.The human storyVaccination and all-cause child mortality from 1985 to 2011: global evidence from the Demographic and Health Surveys.Cost-effectiveness analysis of insecticide-treated net distribution as part of the Togo Integrated Child Health CampaignProtective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial.Assessment of measles immunity among infants in Maputo City, MozambiqueAn evaluation of infant immunization in Africa: is a transformation in progress?A 'post-honeymoon' measles epidemic in Burundi: mathematical model-based analysis and implications for vaccination timingMeasles vaccination: new strategies and formulations.Adding interventions to mass measles vaccinations in India.A review of measles supplementary immunization activities and the implications for Pacific Island countries and territories.Synthesis of Evidence to Characterize National Measles and Rubella Exposure and Immunization Histories.The contribution of child health days to improving coverage of periodic interventions in six African countries.Integrating insecticide-treated bednets into a measles vaccination campaign achieves high, rapid and equitable coverage with direct and voucher-based methods.Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.Improved equity in measles vaccination from integrating insecticide-treated bednets in a vaccination campaign, Madagascar.Measles outbreak in South Africa, 2003-2005.Impact of measles supplementary immunisation activities on utilisation of maternal and child health services in low-income and middle-income countries.The hidden burden of measles in Ethiopia: how distance to hospital shapes the disease mortality rate
P2860
Q26864948-A0C7185E-928A-4A69-92DF-9AAEA887FA86Q27485576-C6361B8F-EC91-4571-A4FF-0DC69DAD5BA0Q28365025-0D15DC8B-96F4-4747-B34C-D668B6C974D5Q28654939-94EB944D-497B-475C-A719-B09E8B5A53F9Q28764037-0E5207C9-2AFA-4236-9A42-DC4EBEC03A8EQ30828665-8FFC0965-55DC-4C7A-9235-8A2435B009DEQ33510450-093D8640-749B-4D76-A327-750321D2FA52Q33875735-3BC9EC5E-3FBA-4F5C-8338-482C63C07DD4Q33909372-FBACA45C-6BBD-43E2-B5D8-CD6538A73965Q34289256-FFEA41E1-2D10-4323-87CA-9F67C34A0413Q35038217-E842D938-4B8E-4DA3-97F5-409092760052Q35106841-B543E2E8-1A1F-4F43-B7CB-35406BE6B751Q35323973-1AC2D0C2-2165-40DA-A736-29D51AFF389AQ35731350-B010B287-AA1E-4234-9B36-BD7A7D2904A2Q35804992-E1AAF09D-EF25-487C-937A-DA97040AA317Q36106722-660C9216-3CE3-44FF-A163-631AA52A35E6Q36322610-54B09DB1-AA90-4E0B-8A22-89B021CCEAAEQ36591733-9BE68555-FF28-42C3-98F1-BA8887A3CA3EQ36677072-57571F4E-C64F-407D-9AC7-5D43EEB63F00Q36818026-875CF80B-F0A9-4070-A36C-67BC8880F505Q37072915-E9BD8515-89C9-469F-81C9-963380E511FAQ37084811-456538E3-4D52-4609-BDBC-A824279B91C4Q37267180-D3E393A5-DB93-4054-B13C-AF25FB2179C3Q37290110-2D73EF56-9AB8-46D6-B8C0-FA94218C460DQ37298486-8062091E-E3E5-45BD-8202-1AF6C8713051Q38969069-450188E2-5877-4325-9E73-805CC9C1726BQ38976888-1A09D5AE-A0D0-439B-BC54-2359C7A2FB3DQ39321740-1D013F80-48D5-4143-B0F6-7D3D3BB3925AQ39734984-1C673369-C3F6-43E7-993A-884BBD1593BCQ40243139-2F656B23-43B1-4EF2-8755-5E2C95ABD829Q41419827-51E01459-02FD-4020-B619-B54DD54F11ACQ47908340-E084CEB1-55E1-4CF9-B15E-F12BC55AB353Q55415859-8EAEAE9C-EB10-4319-846A-6E51AAD2F7C4Q58593257-39A328D8-E4D2-4600-9BC3-CC576F28F15B
P2860
Public-health impact of accelerated measles control in the WHO African Region 2000-03.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Public-health impact of accelerated measles control in the WHO African Region 2000-03.
@ast
Public-health impact of accelerated measles control in the WHO African Region 2000-03.
@en
Public-health impact of accelerated measles control in the WHO African Region 2000-03.
@nl
type
label
Public-health impact of accelerated measles control in the WHO African Region 2000-03.
@ast
Public-health impact of accelerated measles control in the WHO African Region 2000-03.
@en
Public-health impact of accelerated measles control in the WHO African Region 2000-03.
@nl
prefLabel
Public-health impact of accelerated measles control in the WHO African Region 2000-03.
@ast
Public-health impact of accelerated measles control in the WHO African Region 2000-03.
@en
Public-health impact of accelerated measles control in the WHO African Region 2000-03.
@nl
P2093
P921
P1433
P1476
Public-health impact of accelerated measles control in the WHO African Region 2000-03.
@en
P2093
B Masresha
D Nshimirimana
J-M Okwo-Bele
M Grabowsky
P304
P356
10.1016/S0140-6736(05)67216-9
P407
P577
2005-09-01T00:00:00Z